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ABSTRACT 
The effect of the glucocorticoid analogue, dexamethasone, on the development of 
the embryonic pancreas was studied in tissue culture. It specifically enhances the 
accumulation  of  exocrine  enzymes  without  altering  the  level  of  general  cell 
proteins. The enhancement, however, is not symmetrical: the cellular levels of the 
two major exocrine products, amylase and chymotrypsinogen, are increased about 
10-  and  2-fold,  respectively.  Two  other  zymogens  that  are  present  in  minor 
quantities, procarboxypeptidases A  and B, are also increased, whereas no effect is 
seen on lipase A.  Coordinate with these effects on synthesis, there is a  dramatic 
change in the morphology of dexamethasone-stimulated acinar cells. Their num- 
ber of zymogen granules is higher  and crystalline arrays are found in the rough 
endoplasmic reticulum.  Dexamethasone also inhibits cell replication, perhaps by 
selectively inhibiting the last cell divisions of the culture period. At the same time, 
there is a disproportionate reduction in the insulin content of cultured rudiments. 
We find that pancreatic development is normal in the absence of dexametha- 
sone and that this glucocorticoid does not precociously induce the appearance of 
the  specific secretory products,  but  rather  enhances  by a  constant  degree  their 
synthesis and accumulation. Therefore, we conclude that glucocorticoids may play 
a  modulatory but not an inductive role in pancreatic development. 
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Glucocorticoids play a developmental role in a 
variety of tissues,  such as retina (16, 28, 36), skin 
(47), liver (10, 17, 32), lung (1), intestine (25, 26) 
and  mammary gland  (24,  48).  In  these  tissues, 
glucocorticoids  cause  a  precocious or  enhanced 
accumulation of certain proteins and cellular or- 
ganelles characteristic of the differentiated state. 
Where tested, these embryonic tissues contain glu- 
cocorticoid-specific  receptors (1, 13,  15,  21). 
We report here the effects of glucocorticoids  on 
the  in  vitro  development  of the  embryonic rat 
pancreas.  This  system has  been  extensively de- 
scribed at both the morphological and molecular 
levels (30,  31).  As in  vivo, the  embryonic pan- 
creas  cultivated  in  vitro  differentiates into  exo- 
crine (mostly acinar) and endocrine (largely A and 
B) cells. The acinar cells synthesize a set of diges- 
tive  enzymes and  the  endocrine  A  and  B  cells 
produce the  hormones glucagon  and  insulin,  re- 
spectively. 
We  find  that  glucocorticoids  (a)  increase  to 
different degrees the cellular levels of several exo- 
crine enzymes (amylase in particular is induced to 
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vision in the cultured rudiment,  and  (c) decrease 
disproportionately  the  gland  content  of  insulin. 
Our studies of these effects suggest that glucocorti- 
coids modulate but are not themselves the initia- 
tors of developmental events in the pancreas. 
MATERIALS  AND  METHODS 
Organ  Culture and  Tissue Preparation 
Day-13 rat (Sprague-Dawley) embryonic pancreases 
were maintained in organ culture as previously described 
(19).  The  growth  medium  consisted  of  90%  Eagle's 
minimal medium supplemented to three times the usual 
level of the essential amino acids,  10%  chick embryo 
extract (37),  2 mM glutamine,  I00 U/ml of penicillin, 
100  /zg/ml of streptomycin,  and  0.25  /zg/ml of fungi- 
zone. Stock solutions  (10  -3 M) of dexamethasone  and 
hydrocortisone were dissolved  in  absolute ethanol and 
were stored at  -20~  Culture media with or without 
added steroids were prepared and changed daily. Con- 
trol values were not changed by the presence of even 1% 
ethanol. 
At specified times, cultured rudiments were harvested 
(15-20 explants/tube early in development and three to 
four explants/tube  late  in  development) and  stored  in 
Spinco microfuge tubes (Beckman Instruments,  Spinco 
Div., Palo Alto, Calif.) at -75~  At the time of assay, 
they were thawed and subsequently sonicated in an ali- 
quot (usually  150 p.l) of sterile distilled water as detailed 
in reference 19. 
Assays 
The procedures for assaying  insulin  and the exocrine 
proteins  in  pancreatic  sonicates  have  been  described. 
The zymogens were first activated with trypsin  and then 
assayed  with the following substrates"  N-benzoyl-L-tyro- 
sine  ethyl  ester  (BTEE)  (chymotrypsin);  hippuryl-DL- 
phenyllactic acid (HPLA) (carboxypeptidase A), and O- 
hippuryl-L-argininic  acid (HAA) (carboxypeptidase  B). 
Amylase activity was measured by a micromodification 
(42)  of the  Bernfeld technique  (2)  and  lipase  A  was 
assayed  colorimetrically using  fl-naphthyl stearate  as a 
substrate  and in the presence of 0.04 M sodium tauro- 
cholate (3). 
Pancreatic  specific  enzyme  activity is  generally  ex- 
pressed in units, that is, micromoles of substrate  hydro- 
lyzed per minute. These units can be converted to milli- 
grams of enzyme protein since the activities of the pure 
rat enzymes have been determined. For example, amy- 
lase  assays  depend upon  the measurement of reducing 
sugar residues released during the course of starch  hy- 
drolysis.  With pure enzyme and our asssay  conditions, 
260  mg  of  maltose  are  released  per  min  per  mg  of 
amylase  (42).  Similarly,  with  the  assays  described  by 
Sanders and Rutter (43), BTEE is hydrolyzed by pure 
activated chymotrypsinogen at the rate of 80  U/rag of 
enzyme and HAA is hydrolyzed by pure activated pro- 
carboxypeptidase B at the rate of 270 U/rag of zymogen 
(41). In the ease of lipase A and procarboxypeptidase A, 
the turnover numbers of bovine enzymes (40) were used 
since  these two rat enzymes have not been purified to 
homogeneity. 
Insulin  was assayed  by a micromodification (6) of the 
double  antibody  technique  (27)  with  rat  iusulin  as  a 
standard  (33,  34).  Therefore, in the  assay  procedure, 
identical molecules compete for the insulin antibody and 
the values are read directly as picograms of hormone. 
Protein determinations were made by a micromodifica- 
tion  (39)  of the  Folin-Lowry assay.  DNA  and  RNA 
contents were measured by the diphenylamine (5) and 
orcinol  (9)  procedures,  respectively. The sensitivity  of 
the RNA assay was increased by replacing ferric chloride 
with cupric chloride (20) and the values were corrected 
for the known concentrations of DNA in the samples. 
Pancreatic tissues were prepared for light and electron 
microscopy as described previously (19). 
Materials 
All culture media solutions  were from Grand Island 
Biological  Co.  (Grand  Island,  N.  Y.),  except embryo 
extract which was prepared in the laboratory. Starch was 
obtained from Pfanstiehl  Laboratories, Inc. (Waukegan, 
II1.), BTEE from Schwarz/Mann  (Orangeburg, N. Y.), 
HPLA from Cyclo Chemical Co. (Los Angeles, Calif.), 
and fl-naphthyl stearate from Schwarz/Mann. HAA was 
synthesized  by Dr. T.  G. Sanders  (41) and  rat insulin 
was  a  gift  from  Dr.  Schlicktkrull  of Novoterapeutisk 
(Copenhagen, Denmark). 
RESULTS 
Glucocorticoids Increase the Protein 
to DNA  Ratio in the Developing 
Rat Pancreas 
The early embryonic rat pancreas explanted on 
day  13  continues  to  develop  in  vitro  under  our 
conditions.  Over  a  7-day  culture  period  corre- 
sponding to the period between days 13 and 20 of 
embryonic development,  the  total  DNA  content 
of the explant increases  six- to sevenfold and  the 
total  protein  content  15-fold.  Early  in  develop- 
ment (day 13), when the levels of the cell-specific 
products are low, the protein to DNA ratio is ~10 
(see  Fig.  1).  At the end of in utero  development 
(day  20),  the  cells are  larger,  enriched  in  rough 
endoplasmic reticulum and contain high levels of 
secretory  proteins.  These  changes  correlate  with 
an increase in the protein  to DNA ratio to 70. In 
vitro, the protein  to DNA ratio increases only to 
25. If dexamethasone  (10 -7 M) is included in the 
nutrient medium, the protein to DNA ratio of the 
rudiments  increases instead to 50  (Table I). 
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FIGURE 1  Effect  of dexamethasone on the accumula- 
tion of DNA and protein in the developing rat pancreas 
in vitro. Day-13 pancreatic rudiments, including most of 
the associated mesenchyme,  were excised and cultured in 
the presence and absence of  10  -7 M dexamethasone. 
The samples were harvested at the indicated intervals 
and assayed for protein and DNA content. The control 
values represent an average of from three independent 
determinations early in development to ten later in de- 
velopment. They vary by no more than 10%. One ste- 
roid series was assayed except the 20-day results which 
are an average of five different experiments. In total, 
glucocorticoids inhibit one round  of DNA  replication 
and the effect is first observed after 4 days in culture. At 
the  same time,  protein  accumulation continues una- 
bated. 
Glucocorticoids Affect the Cellular 
Levels of Several Exocrine Enzymes 
The exocrine enzymes of the pancreas accumu- 
late to high levels in vitro as in vivo (19, 43). Their 
specific activities based on total protein increase 
by three orders of magnitude between days 13 and 
20  and, with  the  exception of procarboxypepti- 
dase  B,  the  differentiated  levels  are  simlar 
whether expressed in 20-day rudiments or in 13- 
day pancreases after 7 days in culture (Table I). 
However, as shown in Table I, the total protein 
content per differentiated cell in vitro is only one- 
third of that in vivo. Therefore, with the exception 
of  procarboxypeptidase  B,  the  in  vitro  specific 
activities of the cell-specific  proteins expressed on 
a  DNA basis are about one-third of the in vivo 
values. 
When dexamethasone (10 -7 M)  is included in 
the  medium, the final cellular levels of amylase 
and procarboxypeptidase B  are stimulated about 
10-fold. Those of chymotrypsinogen and procar- 
boxypeptidase A  are  increased twofold while li- 
pase A remains unchanged (Table I). The substan- 
tial increase in the cellular levels of amylase and 
chymotrypsinogen,  the two major proteins synthe- 
sized by the pancreas, accounts for the observed 
shift in the total protein to DNA ratio. Thus, by 
difference it can be calculated that  amylase and 
chymotrypsinogen contribute an additional 19 and 
6  Izg of protein, respectively, to account for the 
overall 25 /zg of protein per/zg of DNA increase 
elicited by dexamethasone. Other pancreatic-spe- 
cific products represent a small proportion of the 
total protein content of the  pancreas and there- 
fore,  in the  presence or  absence of dexametha- 
sone, the cellular content of a variety of other cell 
proteins (called in this publication nonspecific pro- 
teins) is quantitatively similar. 
These  results  are  found  at  concentrations of 
dexamethasone that are effective in other systems. 
Fig. 2 shows that a significant stimulation of amy- 
lase  content is  observed  at  10 -a  M  dexametha- 
sone; the half maximal effect occurs at 10  -8 M and 
the  maximal  effect  at  10 -7  M.  Hydrocortisone 
gives  a  similar response,  but  at  50-fold  higher 
concentrations.  In  all  subsequent  experiments, 
dexamethasone, when added, was present at 10 -7 
M. 
Glucocorticoids Do Not Precociously 
Induce Cell-Specific 
Protein Accumulation 
Dexamethasone, while dramatically stimulating 
amylase levels during development, does not pre- 
cociously induce the  appearance  of amylase. In 
the  developing rat  pancreas,  amylase,  like  the 
other exocrine enzymes and insulin, accumulates 
in a biphasic pattern (30, 31, 34, 40). The second- 
ary increase (days 13-18) is exponential, changing 
by an order of magnitude every 2 days in vitro. As 
shown in Fig.  3,  dexamethasone stimulates this 
rate by about 30%, which results in the fourfold 
increase in the final amylase concentration (based 
on total pancreatic protein). However, both accu- 
mulation profiles extrapolate  to  the  same  point 
and therefore, there is no significant change in the 
time of the initial onset of amylase accumulation. 
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Glucocorticoids Modulate the In Vitro Development of the Embryonic Rat Pancreas 
In vitro 
Macroraolecule  In vivo  -  Dex  + Dex 
/zg Protein/pancreas  3,300  150  150 
/zg DNA/pancreas  49  6  3 
Protein/DNA ratio  67  25  50 
Amylase  8.7 (13)  2.8 (11)  21.5 (43) 
Procarboxypeptidase B  0.56 (0.83)  0.025  (0.10)  0.35 (0.70) 
Chymotrypsinogen  20  (30)  6.5 (26)  13  (26) 
Procarboxypeptidase A  2.0 (3.0)  0.58 (2.3)  1.2 (2.4) 
Lipase  0.07 (0.10)  0.03 (0.12)  0.03 (0.06) 
Insulin  0.04 (0.06)  0.07 (0.28)  0.03  (0.06) 
Cell-specific  protein/DNA  31  10  36 
Nonspecific protein/DNA  36  15  14 
Day-13 pancreatic rudiments were grown for a period of 7 days  in the presence of 10  -7 M dexamethasone. Total 
protein, enzyme, and hormone levels are expressed as/zg/p.g DNA. Units of enzyme activity have been converted to 
absolute levels, knowing the turnover numbers of the various enzymes (see Materials and Methods). Numbers in 
parentheses are the same data expressed on a protein basis and multiplied by 100, that is, percent of total pancreatic 
protein.  The higher insulin  specific  concentration in pancreases grown in  vitro as opposed to in vivo is due  to a 
different effect of nutritional conditions on exocrine and endocrine development. However, the effect of dexametha- 
sone is independent of these nutritional conditions. The analysis of these observations will be the subject of another 
report. Protein, DNA, amylase, and insulin values represent an average of 10 (in vitro minus dexamethasone) and 5 
(in vitro plus dexamethasone and in vivo) independent determinations. Other enzyme levels are the average of two 
experiments and in all cases,  the data vary by no more than  10%. 
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FIGURE 2  Effect of increasing concentrations of dexa- 
methasone on the specific activity of amylase in the late 
embryonic pancreas  in  vitro. Day-13  pancreases  were 
cultured for 7 days and then the amylase, protein, and 
DNA content were measured. The results are expressed 
as micrograms of maltose released per minute per micro- 
gram  of protein  or DNA.  In both  cases half-maximal 
effects are  achieved  between  0.5  and  1.0  x  10 -s  M 
dexamethasone. 
Glucocorticoids  Elicit  Ultrastructural 
Changes Reflecting an Increased 
Capacity for the Synthesis and 
Packaging of Acinar Proteins 
The normal  morphological development of the 
exocrine pancreas involves a rapid proliferation of 
the  rough  endoplasmic  reticulum  and  the  subse- 
quent  appearance  of the  first  zymogen  granules 
between  days  16  and  17  in vivo or in pancreatic 
rudiments  explanted on day  13, after 3-4 days in 
culture  (31).  With the exception of a  lower cyto- 
plasmic-nuclear ratio, there are few ultrastructural 
differences between the cells in vitro and in vivo. 
However, if dexamethasone is included in the cul- 
ture  medium, there  is an obvious acceleration  of 
cytodifferentiation in acinar cells. Thus, typically, 
by day  17 in vivo many of the acinar cells contain 
at least a few zymogen granules which are concen- 
trated  in the apical region of the cell. The rough 
endoplasmic reticulum  is oriented  parallel  to  the 
circumference of the nucleus, but is not yet exten- 
sive or laminated. In contrast, at the same stage of 
development in vitro in the presence of dexameth- 
asone, the cytoplasmic distribution  and content of 
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FIGURE  3  Effect  of dexamethasone on the accumula- 
tion of amylase during pancreatic development in vitro. 
Day-13  pancreatic rudiments were excised and cultured 
in the presence and absence of 10  -r M dexamethasone. 
On a  daily  basis, rudiments were  harvested  and then 
assayed for amylase and protein content. The results are 
expressed as micrograms of maltose released per minute 
per microgram  of protein. The conditions and the num- 
ber of samples as well as the variation in the data are as 
in the legend to Fig. I. To insure uniform and extensive 
growth, the early pancreas is cultured in association with 
large amounts of mesenchymal tissue. Early in the cul- 
ture period,  then, the specific activity  of amylase, an 
epithelial product, is artificially lowered. Therefore, to 
more accurately  determine its activity in these samples 
(day 13 plus 1 day in culture only), the mesenchyme was 
mostly excluded. 
rough endoplasmic reticulum is more characteris- 
tic of acinar cells one day later in development. By 
day  19  or  20,  when  cytodifferentiation  is  com- 
plete,  a  light  microscope  comparison  of  control 
(Fig.  4)  and  dexamethasone-treated  rudiments 
(Fig.  5) shows an enhanced number of zymogen 
granules.  Electron  microscopically, this  is corre- 
lated  with  an  increase  in  the  amount  of  rough 
endoplasmic reticulum and in the size of the nu- 
cleoli and, in agreement with these observations, 
the  final cellular content of  RNA  (mostly  ribo- 
somal) is stimulated approx, twofold (3.8 vs. 2.0 
/zg RNA//~g DNA), 
An  unexpected  and  striking feature  of  dexa- 
methasone-treated  tissues is shown in Figs.  6-9. 
Many regions of the rough endoplasmic reticulum 
in the acinar ceils are dilated and contain partially 
condensed  material.  The  cytoplasm  of  many of 
these cells contains linear arrays of a material with 
an electron density similar to that found in zymo- 
gen  granules  (Fig.  6).  The  number and  size  of 
these  inclusions vary greatly  and  they  are  often 
distributed in parallel stacks (Fig. 7). These inclu- 
sions  are  located  in  the  cisternae  of  the  rough 
endoplasmic reticulum (Fig. 8) including the per- 
inuclear cisternae (Fig. 9) and sometimes appear 
crystalline  (Fig.  9).  These  structures  are  found 
only  in  pancreases  cultured  in  the  presence  of 
dexamethasone; we have never seen them in con- 
trol pancreases in vitro or in vivo. 
Glucocorticoids Inhibit  Cell Division 
and Decrease Disproportionately 
the Gland Content of Insulin 
At the same levels at which it potentiates exo- 
trine  cell  development,  dexamethasone  inhibits 
cell division. As shown in Fig. 1, between days 13 
and 20 in control cultures, there is a six- to seven- 
fold increase in the amount of DNA per rudiment. 
If dexamethasone  is included in the  culture me- 
dium, the DNA content of the pancreas increases 
only by  about  3.5-fold.  This inhibition of  DNA 
accumulation is first observed after 4  days in cul- 
ture  when  an  average  of  1.5  rounds  of  DNA 
replication  has  occurred.  Apparently,  then,  the 
last cell divisions of the culture period are blocked 
by the action of dexamethasone. In contrast, over 
the same time period, protein accumulation con- 
tinues unabated. 
If the relative number of insulin-producing  cells 
in cultured rudiments is not altered by the  pres- 
ence of dexamethasone, then one might expect to 
find a twofold lower gland content of hormone in 
proportion  to  the  smaller  total  cell  number.  In 
fact, as calculated from the data presented in Ta- 
ble  1,  there  is  a  disproportionate  fivefoid  lower 
insulin content per differentiated pancreas. These 
402  ThE  JOURNAL  OF  CELL  BIOLOGY ￿9 VOLUME  75,  1977 FIGURES 4 and 5  Acinar cells of dexamethasone-treated pancreatic rudiments accumulate more zymo- 
gen granules. Embryonic pancreases were explanted on day 13 of gestation and cultured in the absence 
(Fig. 4) and presence (Fig. 5) of 10  -t M dexamethasone. In both cases, morphogenetic development is 
normal and acini (arrows) are present.  In the steroid-treated tissue, however, acinar cell cytoplasm is 
darker due to the higher content of zymogens. Both ￿  325. 
changes might be brought about by a reduction in 
the insulin content per cell or in the number of B 
cells present in the tissue. Although quantitative 
morphometry has not been carried out, dexameth- 
asone  must  at  least  decrease  insulin  synthesis 
within  individual cells.  First,  other  experiments 
(M.  de  Gasparo  and  R.  L.  Pictet,  unpublished 
observations) have shown no effect of glucocorti- 
coids on insulin secretion in our in vitro system. 
Second, the addition of glucocorticoids to the cul- 
ture  medium later in  development when  B  cell 
precursors are no longer proliferating reduces the 
hormone content per  rudiment by a  factor of 2 
(33). 
Glucocorticoids Are Not Obligatory for 
Pancreatic Cytodifferentiation 
Although dexamethasone exerts specific  devel- 
opmental effects on the rat pancreas, it is appar- 
ently not obligatorily required for the process of 
cytodifferentiation or the accumulation of the cell- 
specific  proteins. It is of course difficult to assess 
the  contribution of glucocorticoids derived from 
the  maternal circulation. However,  the  rat  pan- 
creas forms midway through gestation (day 11), 2 
days before the appearance of the adrenal cortex 
(38) and, therefore, at a time when no embryoni- 
cally synthesized adrenal cortical hormones can be 
present. Rudiments excised at this early stage ac- 
cumulate amylase and insulin to high levels (Table 
II and reference  45)  during cultivation in a  de- 
fined medium devoid of any steroids. This was ac- 
complished  by  eliminating embryo  extract  or 
bovine serum albumin which contain low amounts 
of glucocorticoids (2 x  10 -9 M and 4 ￿  10 -Jl M in 
10% embryo extract and 0.1% bovine serum al- 
bumin solutions, respectively).  In  addition,  dif- 
ferentiated  (granule-containing) acinar  and  en- 
docrine B cells are readily identifiable in electron 
micrographs. 
RALL ET AL.  Glucocorticoid Modulation of the  Embryonic Rat Pancreas  403 FIGURES  6  and  7  The  cytoplasm of glucocorticoid-stimulated  acinar cells  contains crystalline-shaped, 
electron-dense material.  Day-13 pancreases were cultured for 7  days in the presence of dexamethasone 
(10  -7 M).The differentiated level of several exocrine enzymes is increased and at the same time a variable 
number of cells contains, in addition to the zymogen granules, an electron-dense material (Fig.  6) which 
often is distributed in long, linear, parallel stacks (Fig.  7). This is a striking unusual feature of glucocorti- 
coid-treated  samples; it is never observed in vivo or in  vitro  in the absence of dexamethasone. Fig.  6, 
x  7,500;  Fig.  7,  ￿  35,000. Fr~trt~s  8  and  9  Details  of  dexamethasone-induced,  crystalline  material.  Day-13  pancreases  were 
cultured for 7 days in the presence of dexamethasone (10  -r M). In the presence of glucocorticoids, regions 
of the acinar cell rough endoplasmic reticulum are dilated and contain partially condensed material which is 
in direct continuation with the fully condensed material (Fig.  8).This material sometimes shows a clear 
crystalline pattern (Fig. 9). Fig.  8,  x  123,500; Fig.  9,  ￿  49,500. 
TABLE  II 
Development of the Exocrine and Endocrine Rat Pancreas  in a Completely Defined Medium 
Amylase  InsulitI 
Increase over day-13 level in 
Embryonic age  sp act  vivo  sp act 
Increase over day-13 level in 
vivo 
Day  11  +  5.4  /zg  mal-  1,000-fold  2.92  ng//zg 
9 days in  tose equiv-  protein 
culture  alent//zg 
protein 
1,500-fold 
Day-11 rudiments at the onset of pancreatic organogenesis were excised and cultured under standard conditions. The 
medium was not supplemented with a protein source. After 9 days, amylase and insulin levels were measured. These 
values are minimal since nonpancreatic tissues are included in the sample. They are compared with the low levels 
found in the early 13-day pancreas: amylase, 0.005/zg maltose equivalent per rain per/xg protein, and insulin, 0.002 
ng per ,o.g protein. Day-11 activities have not been similarly determined. 
DISCUSSION 
The exocrine enzymes of the pancreas and insulin 
accumulate  to high levels in vivo and similarly in 
vitro (19, 33, 43).  However, even under enriched 
culture conditions, the cellular content of the exo- 
crine  enzymes  does  not  reach  in  vivo  values. 
Nevertheless,  the  proportion  of cell-specific  pro- 
teins relative to total protein  is similar in the two 
circumstances  (-50%)  (see  Table  I).  Also,  the 
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proteins, amylase and chymotrypsinogen, and of 
two  minor proteins, procarboxypeptidase A  and 
lipase A, are maintained. The differentiated level 
of  procarboxypeptidase B  is  an  exception;  ex- 
pressed on the basis of total protein, it is lower in 
vitro by an order of magnitude. 
Differentiated  exocrine  cells  in  vitro  contain 
about a third of the total protein of exocrine cells 
in vivo. This indicates that the exocrine cells of the 
pancreas  developing  in  vitro  are  smaller  than 
those  in  vivo.  Morphological  observations,  al- 
though  not  quantitative, are consistent with this 
view; that is, granule-containing exocrine cells are 
larger in  size than  their precursor cells, and the 
increased size is not so obvious in pancreases that 
develop in vitro. 
In the presence of low levels of dexamethasone, 
neither the  final cell size as seen  by microscopy 
nor the cellular levels of nonspecific proteins are 
appreciably altered, but there  is a  significant in- 
crease in several exocrine enzymes. The total zy- 
mogen  content  per  cell  late  in  development  in 
vitro  is  stimulated  three-  to  fourfold  and  ap- 
proaches in vivo values. This effect is largely due 
to a 10-fold increase in amylase content and a two- 
fold increase in chymotrypsinogen content. Other 
cell-specific proteins  that  are  present  at  much 
lower  levels are  variously affected.  Procarboxy- 
peptidase  B  levels  are  increased  10-fold,  pro- 
carboxypeptidase A  levels, twofold, and lipase A 
is  unaffected.  Of  the  five  enzymes  measured, 
three of them (procarboxypeptidases A and B and 
chymotrypsinogen) reach levels more closely ap- 
proaching those found in vivo. However, amylase 
levels exceed in vivo values by more than twofold, 
In essence, the presence of glucocorticoids alters 
the intrinsic ratio of one enzyme to another and 
increases  the  proportion  of  pancreatic-specific 
proteins from 50%  to 70%  of the total. 
This  selective stimulation  of  cell-specific pro- 
teins, especially amylase, may be the cause of the 
formation of crystals within the rough endoplas- 
mic reticulum. Similar crystalline arrays have been 
observed  after  the  injection  of p-chlorophenyl- 
alanine (100 mg/kg). However, in this case crystals 
form  within minutes and  are also present in the 
duct lumen (11, 12). The mechanism of this intri- 
guing effect ofp-chlorophenylalanine is unknown, 
but is likely to be different from that documented 
here. 
Glucocorticoid action is not restricted to mam- 
malian pancreatic development. Cohen et al. (8) 
have shown that hydrocortisone elicits increases in 
the levels of certain zymogens, especially chymo- 
trypsinogen, as well as marked cytological changes 
in the developing chick pancreas. The cytological 
effects  of  glucocorticoids involve  the  enhanced 
production of cellular organelles required for the 
synthesis  of large  quantities  of  exportable  pro- 
teins.  They  have  also  been  observed in  the  re- 
sponse of the developing mammary gland to hy- 
drocortisone  (24)  and  in  our  cultured  rat  pan- 
creases.  That  is, in  the  presence  of dexametha- 
sone,  the  elaboration of the  rough  endoplasmic 
reticulum is more extensive and occurs earlier in 
development. The nucleolus is enlarged and after 
7 days in culture there is twice as much total RNA 
per ceU.  These  changes  are  certainly not,  how- 
ever, the sole basis for the glucocorticoid response 
since  they  would  be  expected  to  uniformly en- 
hance the synthesis of the exocrine enzymes (29). 
It  has  been  suggested  that  glucocorticoids may 
alter enzyme levels by in part reducing the rate of 
protein (35)  or mRNA turnover  (46).  We have 
previously shown  that  the  secretory products of 
the developing rat pancreas turn over slowly, if at 
all (19, 33), and their mRNA's, as in other devel- 
oping  systems  (4,  29),  appear  to  be  relatively 
stable. Therefore,  in  this  system  glucocorticoids 
may  selectively increase  the  number  of  certain 
mRNA molecules. Preliminary evidence from our 
laboratory supports this contention  (J.  D.  Hard- 
ing,  R.  J.  MacDonald,  A.  E.  Przybyla,  J.  M. 
Chirgwin,  R.  Pictet,  and  W.  J.  Rutter,  unpub- 
lished observations). 
In  addition  to  their  well-studied induction  of 
tyrosine aminotransferase message (46), glucocor- 
ticoids have been shown to suppress DNA synthe- 
sis in cell lines of liver origin (22). We also observe 
such an inhibition. In the normal development of 
the  pancreas  in  vivo,  there  is  about  a  50-fold 
increase in the total cell number between days 13 
and 20 (33). During the same period in vitro there 
is only a six- to sevenfold change. In the presence 
of dexamethasone, there is an even lower three- to 
fourfold increase in cell number. The DNA accu- 
mulation profiles show that this effect is not imme- 
diate  and  may  reflect a  different  mechanism  of 
control of cell proliferation early and late in em- 
bryonic development. 
Several studies on adult and neonatal rats sug- 
gest that  glucocorticoids also produce effects on 
the  exocrine pancreas similar to those described 
here.  After cortisone administration to neonatal 
rats, the total pancreas RNA content, the size of 
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ules  per cell are  increased.  In  addition,  elevated 
levels of pancreatic amylase and trypsin-like activ- 
ity are detected (44). The timing of the formation 
of the adrenal cortex is compatible with a  role of 
glucocorticoids in certain stages of pancreatic de- 
velopment.  In  the  rat,  the  organization  of  the 
adrenal cortex begins on day 13 (38), 2 days after 
the  initial  formation  of the  pancreatic  diverticu- 
lum. The adrenal gland content (18) and the circu- 
lating  levels  (7)  of  corticosterone,  the  principal 
glucocorticoid of the rat, reach adult levels by day 
17.  Thus,  corticosterone  of  embryonic  origin  is 
present  at high levels at the time of the dramatic 
accumulation  of the exocrine enzymes which  oc- 
curs between days  15 and 20. In spite of this, the 
relative proportion of the various zymogens in the 
in  vivo embryonic pancreas  is different from  the 
proportion found after cultivation with dexameth- 
asone.  Instead,  in  fact,  they  are  similar when  the 
pancreas  is  grown  in  the  absence  of glucocorti- 
coids. In addition, the morphological changes pro- 
duced  by  glucocorticoids  are  never  observed  in 
vivo. 
The  difference  in  the  proportion  of  zymogens 
in vivo and  in vitro in the presence of glucocorti- 
coids may be due to (a) the absence of glucocorti- 
coid receptors in the pancreas in vivo, If this were 
the  case,  our results  would require  the  rapid  in- 
duction of these receptors under our in vitro con- 
ditions.  (b)  Other hormones might act in concert 
with glucocorticoids to balance the synthesis of the 
cell-specific products  or  (c)  glucocorticoid action 
may be antagonized in the fetus. The latter expla- 
nation  is favored since  it is known  that  enzymes 
induced by glucocorticoids in the adult or neonatal 
rat are relatively insensitive to glucocorticoids ad- 
ministered  to the fetus (14).  On the other hand, 
the fetal tissues extirpated  and  cultivated in vitro 
respond  to the hormone  (23). 
The  relatively  late  appearance  of  glucocorti- 
coids plus the results  of our in  vitro experiments 
indicating  that  these  steroids  are  not  obligatorily 
required  for  cytodifferentiation  and  the  accumu- 
lation  of high  levels of the  cell-specific products 
support the contention that glucocorticoids do not 
play  an  instructive  role,  but  rather  may  play  a 
modulatory  role  in  the  development  of the  pan- 
creas. 
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